136 related articles for article (PubMed ID: 32730675)
1. Machine learning applied to atopic dermatitis transcriptome reveals distinct therapy-dependent modification of the keratinocyte immunophenotype.
Clayton K; Vallejo A; Sirvent S; Davies J; Porter G; Reading IC; Lim F; Ardern-Jones MR; Polak ME
Br J Dermatol; 2021 May; 184(5):913-922. PubMed ID: 32730675
[TBL] [Abstract][Full Text] [Related]
2. Progression of acute-to-chronic atopic dermatitis is associated with quantitative rather than qualitative changes in cytokine responses.
Tsoi LC; Rodriguez E; Stölzl D; Wehkamp U; Sun J; Gerdes S; Sarkar MK; Hübenthal M; Zeng C; Uppala R; Xing X; Thielking F; Billi AC; Swindell WR; Shefler A; Chen J; Patrick MT; Harms PW; Kahlenberg JM; Perez White BE; Maverakis E; Gudjonsson JE; Weidinger S
J Allergy Clin Immunol; 2020 May; 145(5):1406-1415. PubMed ID: 31891686
[TBL] [Abstract][Full Text] [Related]
3. Atopic dermatitis displays stable and dynamic skin transcriptome signatures.
Möbus L; Rodriguez E; Harder I; Stölzl D; Boraczynski N; Gerdes S; Kleinheinz A; Abraham S; Heratizadeh A; Handrick C; Haufe E; Werfel T; Schmitt J; Weidinger S;
J Allergy Clin Immunol; 2021 Jan; 147(1):213-223. PubMed ID: 32615169
[TBL] [Abstract][Full Text] [Related]
4. Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis.
Guttman-Yassky E; Bissonnette R; Ungar B; Suárez-Fariñas M; Ardeleanu M; Esaki H; Suprun M; Estrada Y; Xu H; Peng X; Silverberg JI; Menter A; Krueger JG; Zhang R; Chaudhry U; Swanson B; Graham NMH; Pirozzi G; Yancopoulos GD; D Hamilton JD
J Allergy Clin Immunol; 2019 Jan; 143(1):155-172. PubMed ID: 30194992
[TBL] [Abstract][Full Text] [Related]
5. Multiple Transcriptome Data Analysis Reveals Biologically Relevant Atopic Dermatitis Signature Genes and Pathways.
Ghosh D; Ding L; Sivaprasad U; Geh E; Biagini Myers J; Bernstein JA; Khurana Hershey GK; Mersha TB
PLoS One; 2015; 10(12):e0144316. PubMed ID: 26717000
[TBL] [Abstract][Full Text] [Related]
6. The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies.
Brunner PM; Guttman-Yassky E; Leung DY
J Allergy Clin Immunol; 2017 Apr; 139(4S):S65-S76. PubMed ID: 28390479
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel immune and barrier genes in atopic dermatitis by means of laser capture microdissection.
Esaki H; Ewald DA; Ungar B; Rozenblit M; Zheng X; Xu H; Estrada YD; Peng X; Mitsui H; Litman T; Suárez-Fariñas M; Krueger JG; Guttman-Yassky E
J Allergy Clin Immunol; 2015 Jan; 135(1):153-63. PubMed ID: 25567045
[TBL] [Abstract][Full Text] [Related]
8. Use of Tape Strips to Detect Immune and Barrier Abnormalities in the Skin of Children With Early-Onset Atopic Dermatitis.
Guttman-Yassky E; Diaz A; Pavel AB; Fernandes M; Lefferdink R; Erickson T; Canter T; Rangel S; Peng X; Li R; Estrada Y; Xu H; Krueger JG; Paller AS
JAMA Dermatol; 2019 Dec; 155(12):1358-1370. PubMed ID: 31596431
[TBL] [Abstract][Full Text] [Related]
9. Keratinocyte EGF signalling dominates in atopic dermatitis lesions: A comparative RNAseq analysis.
Timms K; Guo H; Arkwright P; Pennock J
Exp Dermatol; 2022 Sep; 31(9):1373-1384. PubMed ID: 35538596
[TBL] [Abstract][Full Text] [Related]
10. Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis.
Hamilton JD; Suárez-Fariñas M; Dhingra N; Cardinale I; Li X; Kostic A; Ming JE; Radin AR; Krueger JG; Graham N; Yancopoulos GD; Pirozzi G; Guttman-Yassky E
J Allergy Clin Immunol; 2014 Dec; 134(6):1293-1300. PubMed ID: 25482871
[TBL] [Abstract][Full Text] [Related]
11. Elevated NK-cell transcriptional signature and dysbalance of resting and activated NK cells in atopic dermatitis.
Möbus L; Rodriguez E; Harder I; Schwarz A; Wehkamp U; Stölzl D; Boraczynski N; Gerdes S; Litman T; Kleinheinz A; Abraham S; Heratizadeh A; Handrick C; Haufe E; Schmitt J; Werfel T; Weidinger S;
J Allergy Clin Immunol; 2021 May; 147(5):1959-1965.e2. PubMed ID: 33390269
[TBL] [Abstract][Full Text] [Related]
12. Etiopathogenesis of atopic dermatitis--an overview.
Pastar Z; Lipozencić J; Ljubojević S
Acta Dermatovenerol Croat; 2005; 13(1):54-62. PubMed ID: 15788148
[TBL] [Abstract][Full Text] [Related]
13. Biologic Therapy for Atopic Dermatitis: Moving Beyond the Practice Parameter and Guidelines.
Boguniewicz M
J Allergy Clin Immunol Pract; 2017; 5(6):1477-1487. PubMed ID: 29122151
[TBL] [Abstract][Full Text] [Related]
14. Single-cell transcriptome analysis of human skin identifies novel fibroblast subpopulation and enrichment of immune subsets in atopic dermatitis.
He H; Suryawanshi H; Morozov P; Gay-Mimbrera J; Del Duca E; Kim HJ; Kameyama N; Estrada Y; Der E; Krueger JG; Ruano J; Tuschl T; Guttman-Yassky E
J Allergy Clin Immunol; 2020 Jun; 145(6):1615-1628. PubMed ID: 32035984
[TBL] [Abstract][Full Text] [Related]
15. Crisaborole and atopic dermatitis skin biomarkers: An intrapatient randomized trial.
Bissonnette R; Pavel AB; Diaz A; Werth JL; Zang C; Vranic I; Purohit VS; Zielinski MA; Vlahos B; Estrada YD; Saint-Cyr Proulx E; Ports WC; Guttman-Yassky E
J Allergy Clin Immunol; 2019 Nov; 144(5):1274-1289. PubMed ID: 31419544
[TBL] [Abstract][Full Text] [Related]
16. Skin programming of inflammatory responses to Staphylococcus aureus is compartmentalized according to epidermal keratinocyte differentiation status.
Clayton K; Holbrook DJ; Vallejo A; Porter G; Sirvent S; Davies J; Pople J; Lim FL; Christodoulides M; Polak ME; Ardern-Jones MR
Br J Dermatol; 2023 Feb; 188(3):396-406. PubMed ID: 36637891
[TBL] [Abstract][Full Text] [Related]
17. Minimally invasive skin tape strip RNA sequencing identifies novel characteristics of the type 2-high atopic dermatitis disease endotype.
Dyjack N; Goleva E; Rios C; Kim BE; Bin L; Taylor P; Bronchick C; Hall CF; Richers BN; Seibold MA; Leung DYM
J Allergy Clin Immunol; 2018 Apr; 141(4):1298-1309. PubMed ID: 29309794
[TBL] [Abstract][Full Text] [Related]
18. The Janus kinase inhibitor JTE-052 improves skin barrier function through suppressing signal transducer and activator of transcription 3 signaling.
Amano W; Nakajima S; Kunugi H; Numata Y; Kitoh A; Egawa G; Dainichi T; Honda T; Otsuka A; Kimoto Y; Yamamoto Y; Tanimoto A; Matsushita M; Miyachi Y; Kabashima K
J Allergy Clin Immunol; 2015 Sep; 136(3):667-677.e7. PubMed ID: 26115905
[TBL] [Abstract][Full Text] [Related]
19. Oral Janus kinase/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis.
Pavel AB; Song T; Kim HJ; Del Duca E; Krueger JG; Dubin C; Peng X; Xu H; Zhang N; Estrada YD; Denis L; Rao N; Gupta S; Zammit DJ; Bissonnette R; Guttman-Yassky E
J Allergy Clin Immunol; 2019 Oct; 144(4):1011-1024. PubMed ID: 31356921
[TBL] [Abstract][Full Text] [Related]
20. Increased IL-26 Expression Promotes T Helper Type 17- and T Helper Type 2-Associated Cytokine Production by Keratinocytes in Atopic Dermatitis.
Kamijo H; Miyagaki T; Hayashi Y; Akatsuka T; Watanabe-Otobe S; Oka T; Shishido-Takahashi N; Suga H; Sugaya M; Sato S
J Invest Dermatol; 2020 Mar; 140(3):636-644.e2. PubMed ID: 31465744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
